Skip to navigation

ASTON/Montag & Caldwell Growth Fund

CUSIP 00078H29900078H28100078H414
Share Class Inception 11/2/19946/28/199612/31/2002
Gross Exp Ratio (%) 1.050.801.30
Net Exp Ratio (%) 1.040.791.29
30 Day Yield (01/31/15) 0.38 0.63 0.13
NAV Change (%) 0.27 0.27 0.27
Dividend Frequency Annual
Benchmark Russell 1000 Growth Index
Morningstar Category Large Growth

Overall Morningstar Rating

ASTON/Montag & Caldwell Growth  Shares received a Morningstar rating.

Among 1538 Large Growth funds derived from a weighted average of the Fund’s 3-, 5- and 10-year risk-adjusted returns as of 1/31/15.

Portfolio Manager

Ronald Canakaris, CFA, Chairman and Chief Investment Officer
Ronald Canakaris, CFA, Chairman and Chief Investment Officer

Ronald Canakaris, CFA, Chairman and Chief Investment Officer

Mr. Canakaris is Chairman of the Board and Chief Investment Officer of Montag & Caldwell. He joined the firm in 1972 and was responsible for the development of the firm's current investment process during the 1970s. He has a BS and BA from the University of Florida.

Investment Strategy

The ASTON/Montag & Caldwell Growth Fund invests in high-quality growth companies that are growing near-term earnings faster than the market and trading at a discount to their intrinsic value.

If you are an investment professional, login or register here for access to Aston’s research content. Discover the unique qualities that differentiate our Subadvisers at both the firm and strategy levels.  


The fund seeks long-term capital appreciation and, secondarily, current income, by investing primarily in common stocks and convertible securities.

Risk Considerations

Growth stocks are generally more sensitive to market moves and thus may be more volatile than other stocks.

Fund Stats (as of 12/31/14) N SharesI SharesR Shares
Origin Of Information FactsetFactsetFactset
Sales Load NoneNoneNone
Total Net Assets (3/4/15)$968,718,925.19$2,476,320,301.91$7,426,756.57
Turnover 47%47%47%
Minimum Investment 2,5001,000,0002,500
Alpha (3 yr.) -1.46-1.27-1.74
Beta (3 yr.) 0.860.860.86
R-Squared (3 yr.) 87.1287.3087.18
Standard Dev (3 yr.) 8.938.958.94
Sharpe Ratio (3 yr.) 1.661.681.63
Current Wtd Average P/E (trailing) 23.4123.4123.41
Current Wtd Average P/B (trailing)
Median Mkt Cap ($Mil) 67,98967,98967,989
Average Wtd Coupon N/AN/AN/A
Effective Maturity N/AN/AN/A
Sector Breakdown (as of 1/31/15)
Health Care
Consumer Staples
Consumer Discretionary
Information Technology
Cash Equivalents & Other
Top 10 Holdings (as of 1/31/15)
CompanyTickerCUSIPNumber of SharesMarket Value% of Net Assets
PEPSICO INC PEP 713448108 1,734,200 $162,633,276.00 4.64%
GILEAD SCIENCES INC GILD 375558103 1,465,100 $153,586,433.00 4.38%
MCKESSON CORP MCK 58155Q103 722,060 $153,546,059.00 4.38%
VISA INC V 92826C839 554,832 $141,432,225.10 4.03%
BIOGEN IDEC INC BIIB 09062X103 354,004 $137,764,196.60 3.93%
MONSANTO CO MON 61166W101 1,122,200 $132,397,156.00 3.77%
MONDELEZ INTERNATIONAL INC MDLZ 609207105 3,728,800 $131,402,912.00 3.75%
ALLERGAN INC/UNITED STATES AGN 18490102 563,362 $123,522,752.10 3.52%
STARBUCKS CORP SBUX 855244109 1,353,500 $118,471,855.00 3.38%
THERMO FISHER SCIENTIFIC INC TMO 883556102 934,300 $116,983,703.00 3.33%
Past performance does not guarantee future results. Investment return and principal value of mutual funds will vary with market conditions, so that shares, when redeemed, may be worth more or less than their original cost.

As the fund is actively managed, the securities as presented may not represent the current or future composition of the portfolio.

Designed and created by DDM Marketing & Communications.